Editas Medicine, Inc. (EDIT)
2.44
-0.09
(-3.56%)
USD |
NASDAQ |
Dec 15, 16:00
2.43
-0.01
(-0.41%)
After-Hours: 20:00
Editas Medicine Accounts Payable (Quarterly): 3.163M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 24.02M |
| Arcutis Biotherapeutics, Inc. | 5.795M |
| Daré Bioscience, Inc. | 1.845M |
| Cogent Biosciences, Inc. | 16.03M |
| Janux Therapeutics, Inc. | 3.395M |